ROLE OF HEPATOCYTE GROWTH-FACTOR IN BREAST-CANCER - A NOVEL MITOGENIC FACTOR SECRETED BY ADIPOCYTES

被引:95
作者
RAHIMI, N
SAULNIER, R
NAKAMURA, T
PARK, M
ELLIOTT, B
机构
[1] QUEENS UNIV,DEPT PATHOL,CANC RES LABS,KINGSTON,ON K7L 3N6,CANADA
[2] OSAKA UNIV,SCH MED,OSAKA,JAPAN
[3] MCGILL UNIV,ROYAL VICTORIA HOSP,MOLEC ONCOL GRP,MONTREAL,PQ H3A 1A1,CANADA
关键词
D O I
10.1089/dna.1994.13.1189
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stromal cells can dramatically affect the growth and metastatic capability of breast carcinoma cells, Growth factors, considered to be important mediators of this process, act as either mitogenic or mite-inhibitory regulators, We have developed an in vitro coculture system to examine the influence of adipocytes, a dominant mammary stromal cell type, on the growth of a murine mammary carcinoma, SP1, Previously, we have reported that conditioned medium (CM) from 3T3-L1 adipocytes can promote in vitro growth of SP1 cells, We now show that the major mitogenic signal derived from 3T3-L1 adipocyte CM is mediated by hepatocyte growth factor (HGF). Neutralizing antibody against HGF at 15 mu g/ml completely abrogated mitogenic activity of 3T3-L1 CM, Furthermore, heparin, an inhibitor of biological activity of HGF, inhibited the mitogenic activity of 3T3-L1 CM, Western blot analysis also confirmed the presence of HGF in 3T3-L1 CM, Although basic fibroblast growth factor (bFGF) and insulin-like growth factor I (IGF-I) were mitogenic for SP1 cells, neutralizing antibodies against IGF-I, bFGF, platelet-derived growth factor (PDGF), and epidermal growth factor (EGF) did not inhibit the mitogenic activity of 3T3-L1 CM, Immunoprecipitation and immunoblotting of HGF receptor/c-met showed that c-met is expressed at high level in SP1 cells, and is phosphorylated following HGF ligation. Together, our present data demonstrate that 3T3-L1 adipocytes secrete HGF, which stimulates SP1 cell growth by a paracrine mechanism. Furthermore, the mitogenic effect of 3T3-L1 CM requires HGF receptor ligation and activation of tyrosine kinase signaling cascades in SP1 cells, These results highlight the importance of stromal-tumor cell interactions and suggest that HGF secreted by adipocytes may be a key regulator of mammary tumor growth,
引用
收藏
页码:1189 / 1197
页数:9
相关论文
共 50 条
[41]   CONTROL OF HEPATOCYTE PROLIFERATION BY HEPATOCYTE GROWTH-FACTOR [J].
MARKER, AJ ;
BUSHFIELD, M ;
PALMER, S ;
GOULD, GW ;
NAKAMURA, T .
GUT, 1991, 32 (07) :A837-A837
[42]   EPIDERMAL GROWTH-FACTOR RECEPTOR IN BREAST-CANCER - COMPARISON WITH NONMALIGNANT BREAST-TISSUE [J].
DITTADI, R ;
DONISI, PM ;
BRAZZALE, A ;
CAPPELLOZZA, L ;
BRUSCAGNIN, G ;
GION, M .
BRITISH JOURNAL OF CANCER, 1993, 67 (01) :7-9
[43]   CONTROL OF HEPATOCYTE PROLIFERATION BY HEPATOCYTE GROWTH-FACTOR [J].
MARKER, AJ ;
BUSHFIELD, M ;
PALMER, S ;
GOULD, GW ;
NAKAMURA, T .
JOURNAL OF PATHOLOGY, 1991, 163 (02) :A177-A177
[44]   SECRETED PROTEINS INDUCED BY EPIDERMAL GROWTH-FACTOR AND TRANSFORMING GROWTH FACTOR-BETA IN EL2 RAT FIBROBLASTS - ROLE IN THE MITOGENIC RESPONSE [J].
DIFRANCESCO, P ;
FAVALLI, C ;
LIBOI, E .
CELL BIOLOGY INTERNATIONAL REPORTS, 1988, 12 (05) :365-372
[45]   The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer [J].
Elliott, BE ;
Hung, WL ;
Boag, AH ;
Tuck, AB .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2002, 80 (02) :91-102
[46]   HEPARIN MODULATES THE RECEPTOR-BINDING AND MITOGENIC ACTIVITY OF HEPATOCYTE GROWTH-FACTOR ON HEPATOCYTES [J].
NAKA, D ;
ISHII, T ;
SHIMOMURA, T ;
HISHIDA, T ;
HARA, H .
EXPERIMENTAL CELL RESEARCH, 1993, 209 (02) :317-324
[47]   SULFATED OLIGOSACCHARIDES PROMOTE HEPATOCYTE GROWTH-FACTOR ASSOCIATION AND GOVERN ITS MITOGENIC ACTIVITY [J].
ZIONCHECK, TF ;
RICHARDSON, L ;
LIU, J ;
CHANG, L ;
KING, KL ;
BENNETT, GL ;
FUGEDI, P ;
CHAMOW, SM ;
SCHWALL, RH ;
STACK, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (28) :16871-16878
[48]   MITOGENIC, DEDIFFERENTIATING, AND SCATTERING EFFECTS OF HEPATOCYTE GROWTH-FACTOR ON DOG THYROID-CELLS [J].
DREMIER, S ;
TATON, M ;
COULONVAL, K ;
NAKAMURA, T ;
MATSUMOTO, K ;
DUMONT, JE .
ENDOCRINOLOGY, 1994, 135 (01) :135-140
[49]   COMPARISON OF BIOCHEMICALLY AND IMMUNOHISTOCHEMICALLY QUANTIFIABLE LEVELS OF EPIDERMAL GROWTH-FACTOR RECEPTOR AS A PROGNOSTIC FACTOR IN BREAST-CANCER [J].
TUTSCHEK, B ;
BECKMANN, MW ;
SCHNURCH, HG ;
KRUGER, KH ;
BENDER, HG .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1993, 254 (1-4) :811-813
[50]   EPIDERMAL GROWTH-FACTOR RECEPTOR ANTIBODIES - EFFECTS ON HUMAN BREAST-CANCER ALLOGRAFTS [J].
SCHNURCH, HG ;
VERING, A ;
STEGMULLER, M ;
BENDER, HG .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1991, 250 (1-4) :239-240